You are here: Home » Current Affairs » Coronavirus » News
Business Standard

India likely to allow export of Sputnik Light Covid shot this month: Report

Indian drugmaker Hetero has already manufactured 2 million doses of the single-shot vaccine

Topics
Coronavirus | Coronavirus Vaccine

Reuters 

Sputnik V
Sputnik V vaccine | Photo: Reuters

India is likely to allow the export of domestically produced doses of Russia's Sputnik Light COVID-19 vaccine this month, as the shot has yet to be approved in India, two sources with knowledge of the matter told Reuters.

Local media have reported that Indian drugmaker Hetero has already manufactured 2 million doses of the single-shot vaccine, for whose approval the country's drug regulator has sought a separate "immune-bridging clinical trial" in its residents.

"Sputnik Light exports are expected to begin from this month," said one of the sources, both of whom declined to be named. "Light is not an approved vaccine in India and stocks are available. There's pressure on the government to export."

Hetero and Dr. Reddy's Laboratories, the Indian partner of Russian sovereign wealth fund RDIF that markets the Sputnik range of vaccines globally, declined to comment. India's health ministry and RDIF did not respond to a request for comment.

Light is the first of two differing components of the two-dose Sputnik V vaccine that has been authorised for emergency use in India and elsewhere. Light has also been approved in many countries but Indian experts want to know if the single-dose vaccine would work well on Indians.

The South Asian country has administered 907,766 Sputnik V doses so far, out of 839.1 million shots given in total.

India will resume exports of approved COVID vaccines, mainly a licensed version of the AstraZeneca shot, in the October quarter after shipments were banned in April when infections surged in the country. Output has jumped since then.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, September 23 2021. 18:47 IST
RECOMMENDED FOR YOU